临床路径对冠心病并2型糖尿病患者实施干预的研究

22602,,,,,2,;Astudyoneffectofclinicalpathappliedforcoronarydiseasewithtype2diabetesmellitusZHAIZhen2dao,HANYu2ting,SUNJin2ping,etal.ThePeoplesHospitalofChangyicityinShanDongProvince,ShanDongChanYi261300,ChinaAbstractObjectiveToexploretheeffectofclinicalpathforcoronarydiseasewithtype2diabetesmellitus.Methods60patientsofcoronarydiseasewithtype2diabetesmellitusweredividedintotwogroups.Thepatientsintheexperimentalgroupreceivedclinicalpathservice.Then,thepatientschangesofheartfunc2tionandqualityinevaluatingdiabetescontrolwascomparedbetweenexperimentalgroupandcontrolgroup.Re2sultsThepatientsheartfunction,FBS,PBS,andHbA1Cinexperimentalgroupwerebetterthanthatcon2trolgroup.ConclusionClinicalpathisaconvenientandeconomicmeans,whichnotonlycanimprovechan2gesofheartfunctionandqualityinevaluatingdiabetescontrol,butalsocanfacilitaterelationshipbetweenthedoctorsandthepatients,andmeetthepatientshealthneeds.KeywordsCoronarydisease;Type2diabetesmellitus;ClinicalPath;Interventionstudy(coronaryarteryheartdisease,CHD),,()(diabetesmellitus,DM),(),,,,2[1],,,11112008620096260,30,112112112,,(ClinicalPath,CP),5;,,,,611212(LVEF)(E)(A)E/A,FBS(mmol/L)2h2hPBS(mmol/L)HbA1C(%);113SPSS1310,,t2211,,2121LVEFEAE/AFBS2hPBSHbA1C(MeanSD)LVEF(%)E(m/s)A(m/s)E/AFBS(mmol/L)PBS(mmol/L)HbA1C(%)30481267124015101160176011501790124810111171214811337198112430571787150301690115301660114301990123351051109361981102351661114330481397114015101140176011401790126719911321219121057197213830511987146015401140170011301750119519611329112211961361112:3P0105:26130041200912434ChinaPracMed,Dec2009,Vol.4,No.34,20081200812157,,,8419%,9612%,9014%,C/E,;;;EfficacyandanalysisofthreeoralChinesemedicinesdrugforchroniccervicitisHONGFeng,ZENGShu2yuan.ThepeopleshospitalofBoluocityinGuangdongProvince,Boluo516100,ChinaAbstractObjectiveTocompareandanalysetheefficacyandeconomyofthreeoralChinesemedi2cinesdrugforchroniccervicitis.Methods157casesofchroniccervicitispatientstreatedinourhospitalfromJannarytoDecemberin2008weredivededintothreegroups.ThetheregroupsweretreatedwithHuahongTab2lets,QianjinTabletsandFuyankangTablets.Clinicalefficacyandeconomywereanalyzed.ResultsTheeffi2cientrateofHuahongTabletswas8419%,QianjinTabletswas9612%andFuyankangTabletswas9014%1TheC/EofQianjinTabletswasthelowest.ConclusionThethreedrugshaveabetterefficacyofthetreatmentofchroniccervicitis,inwhichtheQianjinTabletsismoreeconomicandexcellent.KeywordsChroniccervicitis;Chinesemedicines;efficacy;economicalanalysis:516100,,,,P0105,213,100%,3(ClinicalPathway,CP),,,[2](criti2calpathway),,,[3],,,,[4],,,[5,6],,,,2,,2,:,,;,,;;,,,,,P0105,,,,,,,2,[1],..,2001,29(10):6372639.[2],..,2002,51[3]DewoodyS,PriceJ.A1systemapproachestomultidimensionalarti2clepathsNursingManagement,1994,25(11):47251.[4]11,2004,20(7):4102413.[5],..,2006,21(6):30231.[6]..,2006,22(1B):37238.51200912434ChinaPracMed,Dec2009,Vol.4,No.34